DiagnaMed Launches “Health GenAI”, a New Division for Generative AI Healthcare Solutions
10 mai 2023 07h30 HE
|
Diagnamed Holdings Corp.
TORONTO, May 10, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare solutions company, is pleased to announce the...
DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution
03 mai 2023 07h30 HE
|
Diagnamed Holdings Corp.
TORONTO, May 03, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a generative AI healthcare solutions company, is pleased to announce the...
DiagnaMed Announces Listing on OTCQB in the United States
11 avr. 2023 07h30 HE
|
Diagnamed Holdings Corp.
TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health AI company, is pleased to announce that effective...
DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product
22 mars 2023 07h30 HE
|
Diagnamed Holdings Corp.
TORONTO, March 22, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), a digital health AI company, is pleased to announce the addition of Dr. Bassma Ghali,...
DiagnaMed Announces Application for OTCQB Listing
09 mars 2023 07h30 HE
|
Diagnamed Holdings Corp.
Increasing awareness within the U.S. capital markets DiagnaMed focused on commercializing CERVAI™, its proprietary Brain Health AI Platform leveraging Generative AI TORONTO, March 09, 2023 (GLOBE...
DiagnaMed Enters into License Agreement with University of Miami for Brain Health Platform for Integration with CERVAI™, a Brain Health AI Platform Leveraging Generative AI
22 févr. 2023 07h30 HE
|
Diagnamed Holdings Corp.
TORONTO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), a digital health generative AI company, is pleased to announce that it has entered...
DiagnaMed Prioritizes Development and Commercialization Initiatives for CERVAI™, a Brain Health AI Platform Leveraging Generative AI
14 févr. 2023 07h30 HE
|
Diagnamed Holdings Corp.
TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), a digital health generative AI company, today announces that it is prioritizing...
DiagnaMed Announces Appointment of New Director
13 févr. 2023 07h15 HE
|
Diagnamed Holdings Corp.
TORONTO, Feb. 13, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), a digital health generative AI company, announced today that Ms. Emily Davis resigned...
DiagnaMed Holdings Incorporates OpenAI’s ChatGPT into BRAIN AGE™ AI Product Suite
01 févr. 2023 10h23 HE
|
Diagnamed Holdings Corp.
TORONTO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), an artificial intelligence-driven digital health company focusing on improving brain...
DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023
31 janv. 2023 08h00 HE
|
Diagnamed Holdings Corp.
Complete IRB-approved research study in Q2-2023 Commercialize BRAIN AGE™ in Q4-2023 TORONTO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE:...